Healthcare >> CEO Interviews >> February 24, 1999
STEPHEN A. SHERWIN, M.D. is Chairman, President and Chief Executive
Officer of Cell Genesys. He joined the Company in 1990. Dr. Sherwin
began his career at the National Institutes of Health as an expert in
the biological therapy of cancer and left in 1983 to join Genentech,
Inc. While at Genentech, Dr. Sherwin served as Vice President of
Clinical Research, with responsibility for clinical product development
activities. Dr. Sherwin received his B.A. from Yale University and his
M.D. from Harvard Medical School. Dr. Sherwin is a member of the Board
of Directors of the California Health Care Institute and Chairman of the
Board of Abgenix, Inc. Profile
your activities?
Dr. Sherwin: Cell Genesys is a gene therapy company focused on the
clinical development of cancer and
